1h Free Analyst Time
Molecular Point of Care (mPOC) Devices Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The molecular point of care (mPOC) devices market is poised to grow by $ 816.62 million during 2020-2024 progressing at a CAGR of 15% during the forecast period. The reports on molecular point of care (mPOC) devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of chronic and infectious diseases and the increasing number of M&A activities.
The molecular point of care (mPOC) devices market analysis includes application segment and geographic landscapes.
The molecular point of care (mPOC) devices market is segmented as below:
By Application
- Infectious diseases
- oncology
- others
By Geographic Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the rising number of product launches as one of the prime reasons driving the molecular point of care (mPOC) devices market growth during the next few years.
This study presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The molecular point of care (mPOC) devices market covers the following areas:
- Molecular point of care (mPOC) devices market sizing
- Molecular point of care (mPOC) devices market forecast
- Molecular point of care (mPOC) devices market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading molecular point of care (mPOC) devices market vendors that include Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Credo Biomedical Pte. Ltd., Danaher Corp., F. Hoffmann-La Roche Ltd., Meridian Bioscience Inc., Oxford Nanopore Technologies Ltd., QIAGEN N.V., and QuantuMDx Group Ltd. Also, the molecular point of care (mPOC) devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
This study presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
The market research report provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Application
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global molecular point of care (mPOC) devices market: Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Credo Biomedical Pte. Ltd., Danaher Corp., F. Hoffmann-La Roche Ltd., Meridian Bioscience Inc., Oxford Nanopore Technologies Ltd., QIAGEN N.V., and QuantuMDx Group Ltd.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising number of product launches ."
According to the report, one of the major drivers for this market is the increasing prevalence of chronic and infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- bioMérieux SA
- Bio-Rad Laboratories Inc.
- Credo Biomedical Pte. Ltd.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Meridian Bioscience Inc.
- Oxford Nanopore Technologies Ltd.
- QIAGEN N.V.
- and QuantuMDx Group Ltd.
